Committee for Medicinal Products for Veterinary Use (CVMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024

Committee for Medicinal Products for Veterinary Use (CVMP): 13-15 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2024 to 15 February 2024

Human medicines European public assessment report (EPAR): Exblifep, cefepime,enmetazobactam, Date of authorisation: 21/03/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Exblifep, cefepime,enmetazobactam, Date of authorisation: 21/03/2024, Status: Authorised

Referral: Veterinary medicinal products containing N-methyl pyrrolidone as an excipient Article 82 European Commission final decision, 08/12/2022, 28/03/2023, 22/03/2024

Referral: Veterinary medicinal products containing N-methyl pyrrolidone as an excipient Article 82 European Commission final decision, 08/12/2022, 28/03/2023, 22/03/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness